Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 131 for “"SNCA"”.
-
Cellular pathologies in SNCA mutant neurons: Implications for Parkinson’s disease
Parkinson’s disease (PD) is associated with oxidative stress, a genetic susceptibility to agrochemical exposure, and impaired proteostasis which primarily affect dopaminergic neurons that populate the substantia nigra pars compacta, the region of the PD brain that most prominently degenerates. The …
-
THE NOVEL p.A30G SNCA MUTATION IN GREEK PATIENTS WITH PARKINSON’S DISEASE
… (PD). Μεταλλαγές στο γονίδιο της α-συνουκλεΐνης (SNCA) είναι υπεύθυνες για την αυτοσωμική επικρατή μορφή της νόσου, με την σημειακή μεταλλαγή Α53Τ να είναι η μοναδική, στο γονίδιο αυτό, που έχει ανιχνευτεί μέχρι τώρα στον ελληνικό πληθυσμό. Σε πρόσφατη μελέτη σε Έλληνες ασθενείς ταυτοποιήσαμε μια …
-
Exploring the impact of SNCA overexpression on mouse hippocampal DNA methylome and transcriptome during midlife
… neurodegenerative diseases. Multiplication of SNCA, a gene encoding synaptic protein alpha-synuclein, leads to PD in a dosage-dependent manner. Although the clinical onset of PD generally occurs in late life, it is often preceded by a lengthy prodromal phase that coincides with midlife during …
-
Μελέτη της παθογόνου παραλλαγής p.A30G (c.88C>G) στο γονίδιο SNCA σε ενα ευρύ φάσμα συνουκλεϊνοπάθειών στον ελληνικό πληθυσμό
… παραλλαγής p.A30G (c.88C>G) του γονιδίου SNCA στο πλαίσιο αυτών των διαταραχών στον ελληνικό πληθυσμό. Για την επίτευξη αυτού του σκοπού, μελετήθηκαν 327 ασθενείς με PD (n=271), DLB (n=13), MSA (n=36) ή RBD (n=7) συμπεριλαμβανομένων περιπτώσεων με θετικό οικογενειακό ιστορικό και …
-
The Role Of Α-Synuclein In Brain Lipid Metabolism And Inflammation
Alpha-synuclein (Snca) is a small cytosolic protein that is ubiquitously expressed in the nervous system and comprises 0.5-1% of all cytosolic protein, but its biological function is poorly understood. Although Snca function has been studied in lipid metabolism, the function of Snca in brain lipid …
-
Defining the potential of ZNHIT1, an SNCA co-expressed gene in the substantia nigra, as a therapeutic target for Parkinson’s disease
… increased neurotoxicity and neurodegeneration. SNCA and its mutant variants have been linked to several cases of familial PD. Given the lack of effective disease-modifying therapies, there is an increasing focus on examining SNCA-induced changes in epigenetic regulation in the hopes of …
-
A Role for Parkinson's-Linked LRRK2, SNCA, and GBA1 Genes in Modulating the Course of Disease Due to RNA Virus Infections
… to investigate a role for three PD-linked genes, Snca, Lrrk2, and Gba1, in the host's response to virulent, microbial pathogens in mice. We also sought to explore the neuropathological consequences in the brains of adult mice that survived infections. We previously reported that endogenous …
-
Διερεύνηση μηχανισμών που εμπλέκονται στη μετα-μεταγραφική ρύθμιση της α-συνουκλεΐνης
A-synuclein (SNCA) is a protein mainly expressed in the nervous system, having an important role in neurodegenerative diseases, such as Parkinson's disease (PD) and other neurodegenerative diseases known as synucleopathies. SNCA is the major component of Lewy body (LB) in the sporadic form of …
-
Characterizing the Role of α-Synuclein in Innate Defenses
… genetic and environmental factors. α-Synuclein (SNCA) is central to PD pathogenesis; however, functions of SNCA outside the brain remain largely unknown. We, and others, have found that wild-type Snca expression confers anti-microbial effects in mice by reducing the severity of viral infections. …
-
Study of the transcriptional regulation of α-synuclein
… presynaptic neuronal protein, encoded by the SNCA gene, that is implicated genetically and neuropathologically in Parkinson’s disease (PD). A large body of evidence has established that PD pathogenesis is closely linked to increased levels of SNCA; however to date, the biochemical pathways and …
-
Enfermedad de Parkinson: caracterización de la región 3UTR de los genes SNCA y LRRK2 y del miRNOMA de tejido cerebral y plasma sanguíneo
… genética en la región 3¿UTR de los genes SNCA y LRRK2 y su posible implicación como factor de riesgo o protección de la enfermedad. El segundo objetivo principal se dirigió a la determinación del perfil de expresión de miRNAs en plasma sanguíneo y tejido cerebral proveniente de pacientes …
-
Regulation of alpha-synuclein expression through beta-2-adrenoreceptor agonists: a novel approach towards treating Parkinson's disease
… pathway has been discovered. However, the SNCA gene and its protein product, α-synuclein, have emerged as an important focus in both inherited and sporadic Parkinson's disease. Dosage effects created by duplication and triplication of the SNCA locus can cause the death of dopaminergic …
-
Impairment of chaperone-mediated autophagy and nigrostriatal dopaminergic neurodegeneration in mice: the role of endogenous alpha-synuclein
… της άλφα-συνουκλεΐνης (alpha-synuclein, SNCA) αποτελεί ένα κεντρικό γεγονός στην παθογένεση της νευροεκφύλισης που παρατηρείται στη νόσο Πάρκινσον. Τελευταία δεδομένα δείχνουν ότι η αναστολή των μηχανισμών αποικοδόμησης της SNCA ίσως είναι μείζονος σημασίας στην έναρξη του παθογενετικού …
-
Μετα-μεταγραφική ρύθμιση γονιδίων που εμπλέκονται στις νευροεκφυλιστικές νόσους: ο ρόλος της ΤΙΑ1 στην έκφραση της α-συνουκλεΐνης
… no disease-modifying treatment. A-synuclein (SNCA) is an abundant neuronal protein normally localized in the presynaptic limbs and involved in the pathogenesis of PD, making it a top therapeutic target of interest. The significantly more frequent idiopathic forms of the disease suggest that an …
-
IDENTIFICATION OF ALPHA-SYNUCLEIN DOMINANT MODIFIERS IN A DROSOPHILA MODEL OF NEURODEGENERATION
… assay shows that 12 genes enhance the SNCA-induced neuronal degeneration in cell body and/or synapse. In 6 mutants, the enhanced neurodegeneration phenotype could be rescued by transgenic chromosome fragment containing the candidate gene. Human homologues of several candidate SNCA …
-
Genetic correction of Parkinson’s disease using CRISPR-SKIP
… protein α-synuclein in the brain basal ganglia. SNCA, the gene encoding α-synuclein, when mutated or overexpressed causes misfolding of α-synuclein, which forms toxic aggregates known as Lewy bodies, a characteristic pathological finding in PD. There is no cure for PD and the only treatment …
-
New insights into the development of cerebellar nuclei neurons in mice
… which are immunopositive for α-synuclein (SNCA) and orthodenticle homeobox 2 (Otx2), originate from the mesencephalon and cross the isthmus toward the rostral end of the nuclear transitory zone. Double immunoflourscence of the SNCA with Otx2 or p75 neurotrophin receptor (p75ntr) indicates …
-
Functional characterisation of synuclein-based novel genetic mouse models
… within a bacterial artificial chromosome. <em>SNCA</em>-A30P<sup>+</sup><em>Snca</em>-/- mice exhibited a highly physiologically relevant expression pattern of the transgene, including expression in the substantia nigra pars compacta (SNpc) and a specific, age-related loss of …
-
Studying α-Synuclein pathology using iPSC-derived dopaminergic neurons
… is unknown but a causative role for α-Synuclein (SNCA) has been proposed. Although the function of αSyn is not well understood, a number of pathological mechanisms associated with αSyn toxicity have been proposed. In this study, nine induced pluripotent stem cells (iPSCs) lines from healthy …
Page 1 of 7